What Sagent Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Yanai Shlomo | Director | Aug 29 | Disposition to Issuer · D | −742 | $21.75 | −$16.1K | 0 |
| Flanagan Robert J | Director | Aug 29 | Tender Offer · U | −433,770 | $21.75 | −$9.43M | 0 |
| Flanagan Robert J | Director | Aug 29 | Tender Offer · U | −2,000 | $21.75 | −$43.5K | 0 |
| Flanagan Robert J | Director | Aug 29 | Tender Offer · U | −8,050 | $21.75 | −$175K | 0 |
| Brynjelsen Sean | EVP, Business Development | Aug 29 | Disposition to Issuer · D | −9,844 | $21.75 | −$214K | 0 |
| Vivo Ventures V, Llc | 10% owner | Aug 29 | Tender Offer · U | −34,961 | $21.75 | −$760K | 0 |
| Vivo Ventures V, Llc | 10% owner | Aug 29 | Tender Offer · U | −2,978,803 | $21.75 | −$64.8M | 0 |
| Greve Jeffrey W. | Vice President, Controller | Aug 29 | Disposition to Issuer · D | −4,962 | $21.75 | −$108K | 0 |
| Harmon J Frank | EVP, Global Operations | Aug 29 | Disposition to Issuer · D | −8,915 | $21.75 | −$194K | 0 |
| Ward Michael V. | Chief Legal Off. and Secretary | Aug 29 | Disposition to Issuer · D | −4,962 | $21.75 | −$108K | 0 |
| Ward Michael V. | Chief Legal Off. and Secretary | Aug 29 | Tender Offer · U | −600 | $21.75 | −$13.1K | 0 |
| Ward Michael V. | Chief Legal Off. and Secretary | Aug 29 | Tender Offer · U | −1,000 | $21.75 | −$21.8K | 4,962 |
| Fekete Michael | Director | Aug 29 | Tender Offer · U | −2,041 | $21.75 | −$44.4K | 0 |
| Fekete Michael | Director | Aug 29 | Disposition to Issuer · D | −2,283 | $21.75 | −$49.7K | 2,041 |
| Behrens Mary Taylor | Director | Aug 29 | Tender Offer · U | −7,097 | $21.75 | −$154K | 0 |
| Bullock Donald R | Executive V.P. Sales | Aug 29 | Disposition to Issuer · D | −8,073 | $21.75 | −$176K | 0 |
| Bullock Donald R | Executive V.P. Sales | Aug 29 | Tender Offer · U | −2,583 | $21.75 | −$56.2K | 8,073 |
| Krizman Anthony | Director | Aug 29 | Tender Offer · U | −7,097 | $21.75 | −$154K | 0 |
| Oberman Allan | Chief Executive Officer | Aug 29 | Disposition to Issuer · D | −92,527 | $21.75 | −$2.01M | 0 |
| Oberman Allan | Chief Executive Officer | Aug 29 | Disposition to Issuer · D | −9,459 | $21.75 | −$206K | 92,527 |
Loading...
